Cargando…
Reversal of subcellular remodelling by losartan in heart failure due to myocardial infarction
This study tested the reversal of subcellular remodelling in heart failure due to myocardial infarction (MI) upon treatment with losartan, an angiotensin II receptor antagonist. Twelve weeks after inducing MI, rats were treated with or without losartan (20 mg/kg; daily) for 8 weeks and assessed for...
Autores principales: | Babick, Andrea, Chapman, Donald, Zieroth, Shelley, Elimban, Vijayan, Dhalla, Naranjan S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4393724/ https://www.ncbi.nlm.nih.gov/pubmed/22947202 http://dx.doi.org/10.1111/j.1582-4934.2012.01623.x |
Ejemplares similares
-
Involvement of Oxidative Stress in the Development of Subcellular Defects and Heart Disease
por: Dhalla, Naranjan S., et al.
Publicado: (2022) -
Antiplatelet therapy attenuates subcellular remodelling in congestive heart failure
por: Sanganalmath, Santosh K, et al.
Publicado: (2008) -
β-adrenergic blockade attenuates cardiac dysfunction and myofibrillar remodelling in congestive heart failure
por: Machackova, Jarmila, et al.
Publicado: (2011) -
Oxidative Stress as A Mechanism for Functional Alterations in Cardiac Hypertrophy and Heart Failure
por: Shah, Anureet K., et al.
Publicado: (2021) -
Reduction of blood pressure by store‐operated calcium channel blockers
por: Xu, Yan‐Jun, et al.
Publicado: (2015)